|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:EBNA1BP2-FMO3 (FusionGDB2 ID:24812) |
Fusion Gene Summary for EBNA1BP2-FMO3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: EBNA1BP2-FMO3 | Fusion gene ID: 24812 | Hgene | Tgene | Gene symbol | EBNA1BP2 | FMO3 | Gene ID | 10969 | 2328 |
Gene name | EBNA1 binding protein 2 | flavin containing dimethylaniline monoxygenase 3 | |
Synonyms | EBP2|NOBP|P40 | FMOII|TMAU|dJ127D3.1 | |
Cytomap | 1p34.2 | 1q24.3 | |
Type of gene | protein-coding | protein-coding | |
Description | probable rRNA-processing protein EBP2nuclear FGF3 binding proteinnucleolar protein p40nucleolar protein p40; homolog of yeast EBNA1-binding protein | dimethylaniline monooxygenase [N-oxide-forming] 3FMO form 2dimethylaniline oxidase 3flavin containing monooxygenase 3hepatic flavin-containing monooxygenase-3trimethylamine monooxygenase | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q99848 | P31513 | |
Ensembl transtripts involved in fusion gene | ENST00000431635, ENST00000236051, ENST00000472982, | ENST00000392085, ENST00000367755, ENST00000542847, ENST00000534514, ENST00000538429, | |
Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 3 X 5 X 3=45 |
# samples | 2 | 3 | |
** MAII score | log2(2/8*10)=1.32192809488736 | log2(3/45*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: EBNA1BP2 [Title/Abstract] AND FMO3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | EBNA1BP2(43634610)-FMO3(171072926), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across EBNA1BP2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across FMO3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LIHC | TCGA-EP-A3RK-01A | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
Top |
Fusion Gene ORF analysis for EBNA1BP2-FMO3 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000431635 | ENST00000392085 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
In-frame | ENST00000431635 | ENST00000367755 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
In-frame | ENST00000431635 | ENST00000542847 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
5CDS-intron | ENST00000431635 | ENST00000534514 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
5CDS-intron | ENST00000431635 | ENST00000538429 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
In-frame | ENST00000236051 | ENST00000392085 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
In-frame | ENST00000236051 | ENST00000367755 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
In-frame | ENST00000236051 | ENST00000542847 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
5CDS-intron | ENST00000236051 | ENST00000534514 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
5CDS-intron | ENST00000236051 | ENST00000538429 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
intron-3CDS | ENST00000472982 | ENST00000392085 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
intron-3CDS | ENST00000472982 | ENST00000367755 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
intron-3CDS | ENST00000472982 | ENST00000542847 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
intron-intron | ENST00000472982 | ENST00000534514 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
intron-intron | ENST00000472982 | ENST00000538429 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000431635 | EBNA1BP2 | chr1 | 43634610 | - | ENST00000392085 | FMO3 | chr1 | 171072926 | + | 2691 | 851 | 50 | 2317 | 755 |
ENST00000431635 | EBNA1BP2 | chr1 | 43634610 | - | ENST00000367755 | FMO3 | chr1 | 171072926 | + | 2695 | 851 | 50 | 2317 | 755 |
ENST00000431635 | EBNA1BP2 | chr1 | 43634610 | - | ENST00000542847 | FMO3 | chr1 | 171072926 | + | 2343 | 851 | 50 | 2317 | 755 |
ENST00000236051 | EBNA1BP2 | chr1 | 43634610 | - | ENST00000392085 | FMO3 | chr1 | 171072926 | + | 2519 | 679 | 142 | 2145 | 667 |
ENST00000236051 | EBNA1BP2 | chr1 | 43634610 | - | ENST00000367755 | FMO3 | chr1 | 171072926 | + | 2523 | 679 | 142 | 2145 | 667 |
ENST00000236051 | EBNA1BP2 | chr1 | 43634610 | - | ENST00000542847 | FMO3 | chr1 | 171072926 | + | 2171 | 679 | 142 | 2145 | 667 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000431635 | ENST00000392085 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + | 0.001788955 | 0.998211 |
ENST00000431635 | ENST00000367755 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + | 0.001734649 | 0.9982653 |
ENST00000431635 | ENST00000542847 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + | 0.002446573 | 0.9975534 |
ENST00000236051 | ENST00000392085 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + | 0.001475166 | 0.99852484 |
ENST00000236051 | ENST00000367755 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + | 0.001428726 | 0.9985713 |
ENST00000236051 | ENST00000542847 | EBNA1BP2 | chr1 | 43634610 | - | FMO3 | chr1 | 171072926 | + | 0.002277599 | 0.99772245 |
Top |
Fusion Genomic Features for EBNA1BP2-FMO3 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
EBNA1BP2 | chr1 | 43634609 | - | FMO3 | chr1 | 171072925 | + | 0.017357437 | 0.98264253 |
EBNA1BP2 | chr1 | 43634609 | - | FMO3 | chr1 | 171072925 | + | 0.017357437 | 0.98264253 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for EBNA1BP2-FMO3 |
Go to FGviewer for the breakpoints of chr1:43634610-chr1:171072926 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
EBNA1BP2 | FMO3 |
FUNCTION: Required for the processing of the 27S pre-rRNA. {ECO:0000250}. | FUNCTION: Essential hepatic enzyme that catalyzes the oxygenation of a wide variety of nitrogen- and sulfur-containing compounds including drugs as well as dietary compounds (PubMed:10759686, PubMed:30381441). Plays an important role in the metabolism of trimethylamine (TMA), via the production of trimethylamine N-oxide (TMAO) metabolite (PubMed:9776311). TMA is generated by the action of gut microbiota using dietary precursors such as choline, choline containing compounds, betaine or L-carnitine. By regulating TMAO concentration, FMO3 directly impacts both platelet responsiveness and rate of thrombus formation (PubMed:29981269). {ECO:0000250|UniProtKB:P97501, ECO:0000269|PubMed:10759686, ECO:0000269|PubMed:29981269, ECO:0000269|PubMed:30381441, ECO:0000269|PubMed:9224773, ECO:0000269|PubMed:9776311}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | EBNA1BP2 | chr1:43634610 | chr1:171072926 | ENST00000236051 | - | 5 | 9 | 138_169 | 179.0 | 307.0 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | FMO3 | chr1:43634610 | chr1:171072926 | ENST00000367755 | 1 | 9 | 195_198 | 44.0 | 533.0 | Nucleotide binding | NADP | |
Tgene | FMO3 | chr1:43634610 | chr1:171072926 | ENST00000367755 | 1 | 9 | 60_61 | 44.0 | 533.0 | Nucleotide binding | NADP | |
Tgene | FMO3 | chr1:43634610 | chr1:171072926 | ENST00000367755 | 1 | 9 | 61_62 | 44.0 | 533.0 | Nucleotide binding | FAD | |
Tgene | FMO3 | chr1:43634610 | chr1:171072926 | ENST00000392085 | 1 | 9 | 195_198 | 44.0 | 533.0 | Nucleotide binding | NADP | |
Tgene | FMO3 | chr1:43634610 | chr1:171072926 | ENST00000392085 | 1 | 9 | 60_61 | 44.0 | 533.0 | Nucleotide binding | NADP | |
Tgene | FMO3 | chr1:43634610 | chr1:171072926 | ENST00000392085 | 1 | 9 | 61_62 | 44.0 | 533.0 | Nucleotide binding | FAD | |
Tgene | FMO3 | chr1:43634610 | chr1:171072926 | ENST00000367755 | 1 | 9 | 510_530 | 44.0 | 533.0 | Transmembrane | Helical | |
Tgene | FMO3 | chr1:43634610 | chr1:171072926 | ENST00000392085 | 1 | 9 | 510_530 | 44.0 | 533.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | FMO3 | chr1:43634610 | chr1:171072926 | ENST00000367755 | 1 | 9 | 40_41 | 44.0 | 533.0 | Nucleotide binding | FAD | |
Tgene | FMO3 | chr1:43634610 | chr1:171072926 | ENST00000367755 | 1 | 9 | 9_13 | 44.0 | 533.0 | Nucleotide binding | FAD | |
Tgene | FMO3 | chr1:43634610 | chr1:171072926 | ENST00000392085 | 1 | 9 | 40_41 | 44.0 | 533.0 | Nucleotide binding | FAD | |
Tgene | FMO3 | chr1:43634610 | chr1:171072926 | ENST00000392085 | 1 | 9 | 9_13 | 44.0 | 533.0 | Nucleotide binding | FAD |
Top |
Fusion Gene Sequence for EBNA1BP2-FMO3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000431635_ENST00000392085_TCGA-EP-A3RK-01A_EBNA1BP2_chr1_43634610_-_FMO3_chr1_171072926_length(transcript)=2691nt_BP=851nt CCTCCCCCGGGGTCCTCCTCCGCGCCACCCCACCCCCGCGGCTCCTTTTTCTGCCTTTTCCTTTGTACCCTCACTGCTACCAGCTCCTTC TGGCGACCCCCAGGTACCCCCTCCCACCTTTCGTTTCTCTCTGGGTCAGCAGACCACGCATGTATCCAGAGGCGCTACCTGTAGGGATCC TAAGCAACCCGGACACTTTCAAACGCCGTAGCGGTTCCTATAGCAACGACAAACCGGAAGTATGGTTTGCCGCCGGAAGCGGAAGTCCCA ATCAAAAGTTGAGCAGTAGCTGTGTGGGACGTGCGTGCGGCGAGATGGACACTCCCCCGCTCTCGGATTCGGAGTCGGAATCCGATGAAT CCCTTGTCACAGACAGAGAGTTGCAGGATGCGTTTTCCCGAGGGCTTCTGAAGCCAGGCCTCAATGTCGTGCTAGAGGGGCCGAAGAAGG CCGTGAACGACGTGAATGGCCTGAAGCAATGTTTGGCAGAATTCAAGCGGGATCTGGAATGGGTTGAAAGGCTCGATGTGACACTGGGTC CGGTACCGGAGATCGGTGGATCTGAGGCGCCAGCACCTCAGAACAAGGACCAGAAAGCTGTTGATCCAGAAGACGACTTCCAGCGAGAGA TGAGTTTCTATCGCCAAGCCCAGGCCGCAGTGCTTGCAGTCTTACCCCGCCTCCATCAGCTCAAAGTCCCTACGAAGCGACCCACTGATT ATTTTGCGGAAATGGCCAAATCTGATCTGCAGATGCAGAAGATTCGACAGAAGCTGCAGACTAAACAGGCTGCCATGGAGAGGTCTGAAA AAGCTAAGCAACTGCGAGCACTTAGGAAATACGGGAAGAAGGACCATGCAGAGGAGGGCAGGGCTAGCATTTACAAATCAGTCTTTTCCA ACTCTTCCAAAGAGATGATGTGTTTCCCAGACTTCCCATTTCCCGATGACTTCCCCAACTTTATGCACAACAGCAAGATCCAGGAATATA TCATTGCATTTGCCAAAGAAAAGAACCTCCTGAAGTACATACAATTTAAGACATTTGTATCCAGTGTAAATAAACATCCTGATTTTGCAA CTACTGGCCAGTGGGATGTTACCACTGAAAGGGATGGTAAAAAAGAATCGGCTGTCTTTGATGCTGTAATGGTTTGTTCCGGACATCATG TGTATCCCAACCTACCAAAAGAGTCCTTTCCAGGACTAAACCACTTTAAAGGCAAATGCTTCCACAGCAGGGACTATAAAGAACCAGGTG TATTCAATGGAAAGCGTGTCCTGGTGGTTGGCCTGGGGAATTCGGGCTGTGATATTGCCACAGAACTCAGCCGCACAGCAGAACAGGTCA TGATCAGTTCCAGAAGTGGCTCCTGGGTGATGAGCCGGGTCTGGGACAATGGTTATCCTTGGGACATGCTGCTCGTCACTCGATTTGGAA CCTTCCTCAAGAACAATTTACCGACAGCCATCTCTGACTGGTTGTACGTGAAGCAGATGAATGCAAGATTCAAGCATGAAAACTATGGCT TGATGCCTTTAAATGGAGTCCTGAGGAAAGAGCCTGTATTTAACGATGAGCTCCCAGCAAGCATTCTGTGTGGCATTGTGTCCGTAAAGC CTAACGTGAAGGAATTCACAGAGACCTCGGCCATTTTTGAGGATGGGACCATATTTGAGGGCATTGACTGTGTAATCTTTGCAACAGGGT ATAGTTTTGCCTACCCCTTCCTTGATGAGTCTATCATCAAAAGCAGAAACAATGAGATCATTTTATTTAAAGGAGTATTTCCTCCTCTAC TTGAGAAGTCAACCATAGCAGTGATTGGCTTTGTCCAGTCCCTTGGGGCTGCCATTCCCACAGTTGACCTCCAGTCCCGCTGGGCAGCAC AAGTAATAAAGGGAACTTGTACTTTGCCTTCTATGGAAGACATGATGAATGATATTAATGAGAAAATGGAGAAAAAGCGCAAATGGTTTG GCAAAAGCGAGACCATACAGACAGATTACATTGTTTATATGGATGAACTCTCCTCCTTCATTGGGGCAAAGCCCAACATCCCATGGCTGT TTCTCACAGATCCCAAATTGGCCATGGAAGTTTATTTTGGCCCTTGTAGTCCCTACCAGTTTAGGCTGGTGGGCCCAGGGCAGTGGCCAG GAGCCAGAAATGCCATACTGACCCAGTGGGACCGGTCGTTGAAACCCATGCAGACACGAGTGGTCGGGAGACTTCAGAAGCCTTGCTTCT TTTTCCATTGGCTGAAGCTCTTTGCAATTCCTATTCTGTTAATCGCTGTTTTCCTTGTGTTGACCTAATCATCATTTTCTCTAGGATTTC TGAAAGTTACTGACAATACCCAGACAGGGGCTTTGCTATTTAAAAATTAAAATTTTCACACCACCTGCTTTTCTATTCAGCATCTTTTGC AGTACTCTGTAGACATTAGTCAGTAATACAGTGTTATTTCTAGGCTCTGAAATAGCCACTTTAAGAATCATGTCATGATCTTAAGAGAGC ACTAATCATTTCTGTTTGAGTTCCACTAACACTTCAAAATCAGAACTATGTTCTTTATATCTAACTTAAATCATTTCCTGAAACATTTTG >In-frame_ENST00000431635_ENST00000392085_TCGA-EP-A3RK-01A_EBNA1BP2_chr1_43634610_-_FMO3_chr1_171072926_length(amino acids)=755AA_start in transcript=50_stop in transcript=2317 MPFPLYPHCYQLLLATPRYPLPPFVSLWVSRPRMYPEALPVGILSNPDTFKRRSGSYSNDKPEVWFAAGSGSPNQKLSSSCVGRACGEMD TPPLSDSESESDESLVTDRELQDAFSRGLLKPGLNVVLEGPKKAVNDVNGLKQCLAEFKRDLEWVERLDVTLGPVPEIGGSEAPAPQNKD QKAVDPEDDFQREMSFYRQAQAAVLAVLPRLHQLKVPTKRPTDYFAEMAKSDLQMQKIRQKLQTKQAAMERSEKAKQLRALRKYGKKDHA EEGRASIYKSVFSNSSKEMMCFPDFPFPDDFPNFMHNSKIQEYIIAFAKEKNLLKYIQFKTFVSSVNKHPDFATTGQWDVTTERDGKKES AVFDAVMVCSGHHVYPNLPKESFPGLNHFKGKCFHSRDYKEPGVFNGKRVLVVGLGNSGCDIATELSRTAEQVMISSRSGSWVMSRVWDN GYPWDMLLVTRFGTFLKNNLPTAISDWLYVKQMNARFKHENYGLMPLNGVLRKEPVFNDELPASILCGIVSVKPNVKEFTETSAIFEDGT IFEGIDCVIFATGYSFAYPFLDESIIKSRNNEIILFKGVFPPLLEKSTIAVIGFVQSLGAAIPTVDLQSRWAAQVIKGTCTLPSMEDMMN DINEKMEKKRKWFGKSETIQTDYIVYMDELSSFIGAKPNIPWLFLTDPKLAMEVYFGPCSPYQFRLVGPGQWPGARNAILTQWDRSLKPM -------------------------------------------------------------- >In-frame_ENST00000431635_ENST00000367755_TCGA-EP-A3RK-01A_EBNA1BP2_chr1_43634610_-_FMO3_chr1_171072926_length(transcript)=2695nt_BP=851nt CCTCCCCCGGGGTCCTCCTCCGCGCCACCCCACCCCCGCGGCTCCTTTTTCTGCCTTTTCCTTTGTACCCTCACTGCTACCAGCTCCTTC TGGCGACCCCCAGGTACCCCCTCCCACCTTTCGTTTCTCTCTGGGTCAGCAGACCACGCATGTATCCAGAGGCGCTACCTGTAGGGATCC TAAGCAACCCGGACACTTTCAAACGCCGTAGCGGTTCCTATAGCAACGACAAACCGGAAGTATGGTTTGCCGCCGGAAGCGGAAGTCCCA ATCAAAAGTTGAGCAGTAGCTGTGTGGGACGTGCGTGCGGCGAGATGGACACTCCCCCGCTCTCGGATTCGGAGTCGGAATCCGATGAAT CCCTTGTCACAGACAGAGAGTTGCAGGATGCGTTTTCCCGAGGGCTTCTGAAGCCAGGCCTCAATGTCGTGCTAGAGGGGCCGAAGAAGG CCGTGAACGACGTGAATGGCCTGAAGCAATGTTTGGCAGAATTCAAGCGGGATCTGGAATGGGTTGAAAGGCTCGATGTGACACTGGGTC CGGTACCGGAGATCGGTGGATCTGAGGCGCCAGCACCTCAGAACAAGGACCAGAAAGCTGTTGATCCAGAAGACGACTTCCAGCGAGAGA TGAGTTTCTATCGCCAAGCCCAGGCCGCAGTGCTTGCAGTCTTACCCCGCCTCCATCAGCTCAAAGTCCCTACGAAGCGACCCACTGATT ATTTTGCGGAAATGGCCAAATCTGATCTGCAGATGCAGAAGATTCGACAGAAGCTGCAGACTAAACAGGCTGCCATGGAGAGGTCTGAAA AAGCTAAGCAACTGCGAGCACTTAGGAAATACGGGAAGAAGGACCATGCAGAGGAGGGCAGGGCTAGCATTTACAAATCAGTCTTTTCCA ACTCTTCCAAAGAGATGATGTGTTTCCCAGACTTCCCATTTCCCGATGACTTCCCCAACTTTATGCACAACAGCAAGATCCAGGAATATA TCATTGCATTTGCCAAAGAAAAGAACCTCCTGAAGTACATACAATTTAAGACATTTGTATCCAGTGTAAATAAACATCCTGATTTTGCAA CTACTGGCCAGTGGGATGTTACCACTGAAAGGGATGGTAAAAAAGAATCGGCTGTCTTTGATGCTGTAATGGTTTGTTCCGGACATCATG TGTATCCCAACCTACCAAAAGAGTCCTTTCCAGGACTAAACCACTTTAAAGGCAAATGCTTCCACAGCAGGGACTATAAAGAACCAGGTG TATTCAATGGAAAGCGTGTCCTGGTGGTTGGCCTGGGGAATTCGGGCTGTGATATTGCCACAGAACTCAGCCGCACAGCAGAACAGGTCA TGATCAGTTCCAGAAGTGGCTCCTGGGTGATGAGCCGGGTCTGGGACAATGGTTATCCTTGGGACATGCTGCTCGTCACTCGATTTGGAA CCTTCCTCAAGAACAATTTACCGACAGCCATCTCTGACTGGTTGTACGTGAAGCAGATGAATGCAAGATTCAAGCATGAAAACTATGGCT TGATGCCTTTAAATGGAGTCCTGAGGAAAGAGCCTGTATTTAACGATGAGCTCCCAGCAAGCATTCTGTGTGGCATTGTGTCCGTAAAGC CTAACGTGAAGGAATTCACAGAGACCTCGGCCATTTTTGAGGATGGGACCATATTTGAGGGCATTGACTGTGTAATCTTTGCAACAGGGT ATAGTTTTGCCTACCCCTTCCTTGATGAGTCTATCATCAAAAGCAGAAACAATGAGATCATTTTATTTAAAGGAGTATTTCCTCCTCTAC TTGAGAAGTCAACCATAGCAGTGATTGGCTTTGTCCAGTCCCTTGGGGCTGCCATTCCCACAGTTGACCTCCAGTCCCGCTGGGCAGCAC AAGTAATAAAGGGAACTTGTACTTTGCCTTCTATGGAAGACATGATGAATGATATTAATGAGAAAATGGAGAAAAAGCGCAAATGGTTTG GCAAAAGCGAGACCATACAGACAGATTACATTGTTTATATGGATGAACTCTCCTCCTTCATTGGGGCAAAGCCCAACATCCCATGGCTGT TTCTCACAGATCCCAAATTGGCCATGGAAGTTTATTTTGGCCCTTGTAGTCCCTACCAGTTTAGGCTGGTGGGCCCAGGGCAGTGGCCAG GAGCCAGAAATGCCATACTGACCCAGTGGGACCGGTCGTTGAAACCCATGCAGACACGAGTGGTCGGGAGACTTCAGAAGCCTTGCTTCT TTTTCCATTGGCTGAAGCTCTTTGCAATTCCTATTCTGTTAATCGCTGTTTTCCTTGTGTTGACCTAATCATCATTTTCTCTAGGATTTC TGAAAGTTACTGACAATACCCAGACAGGGGCTTTGCTATTTAAAAATTAAAATTTTCACACCACCTGCTTTTCTATTCAGCATCTTTTGC AGTACTCTGTAGACATTAGTCAGTAATACAGTGTTATTTCTAGGCTCTGAAATAGCCACTTTAAGAATCATGTCATGATCTTAAGAGAGC ACTAATCATTTCTGTTTGAGTTCCACTAACACTTCAAAATCAGAACTATGTTCTTTATATCTAACTTAAATCATTTCCTGAAACATTTTG >In-frame_ENST00000431635_ENST00000367755_TCGA-EP-A3RK-01A_EBNA1BP2_chr1_43634610_-_FMO3_chr1_171072926_length(amino acids)=755AA_start in transcript=50_stop in transcript=2317 MPFPLYPHCYQLLLATPRYPLPPFVSLWVSRPRMYPEALPVGILSNPDTFKRRSGSYSNDKPEVWFAAGSGSPNQKLSSSCVGRACGEMD TPPLSDSESESDESLVTDRELQDAFSRGLLKPGLNVVLEGPKKAVNDVNGLKQCLAEFKRDLEWVERLDVTLGPVPEIGGSEAPAPQNKD QKAVDPEDDFQREMSFYRQAQAAVLAVLPRLHQLKVPTKRPTDYFAEMAKSDLQMQKIRQKLQTKQAAMERSEKAKQLRALRKYGKKDHA EEGRASIYKSVFSNSSKEMMCFPDFPFPDDFPNFMHNSKIQEYIIAFAKEKNLLKYIQFKTFVSSVNKHPDFATTGQWDVTTERDGKKES AVFDAVMVCSGHHVYPNLPKESFPGLNHFKGKCFHSRDYKEPGVFNGKRVLVVGLGNSGCDIATELSRTAEQVMISSRSGSWVMSRVWDN GYPWDMLLVTRFGTFLKNNLPTAISDWLYVKQMNARFKHENYGLMPLNGVLRKEPVFNDELPASILCGIVSVKPNVKEFTETSAIFEDGT IFEGIDCVIFATGYSFAYPFLDESIIKSRNNEIILFKGVFPPLLEKSTIAVIGFVQSLGAAIPTVDLQSRWAAQVIKGTCTLPSMEDMMN DINEKMEKKRKWFGKSETIQTDYIVYMDELSSFIGAKPNIPWLFLTDPKLAMEVYFGPCSPYQFRLVGPGQWPGARNAILTQWDRSLKPM -------------------------------------------------------------- >In-frame_ENST00000431635_ENST00000542847_TCGA-EP-A3RK-01A_EBNA1BP2_chr1_43634610_-_FMO3_chr1_171072926_length(transcript)=2343nt_BP=851nt CCTCCCCCGGGGTCCTCCTCCGCGCCACCCCACCCCCGCGGCTCCTTTTTCTGCCTTTTCCTTTGTACCCTCACTGCTACCAGCTCCTTC TGGCGACCCCCAGGTACCCCCTCCCACCTTTCGTTTCTCTCTGGGTCAGCAGACCACGCATGTATCCAGAGGCGCTACCTGTAGGGATCC TAAGCAACCCGGACACTTTCAAACGCCGTAGCGGTTCCTATAGCAACGACAAACCGGAAGTATGGTTTGCCGCCGGAAGCGGAAGTCCCA ATCAAAAGTTGAGCAGTAGCTGTGTGGGACGTGCGTGCGGCGAGATGGACACTCCCCCGCTCTCGGATTCGGAGTCGGAATCCGATGAAT CCCTTGTCACAGACAGAGAGTTGCAGGATGCGTTTTCCCGAGGGCTTCTGAAGCCAGGCCTCAATGTCGTGCTAGAGGGGCCGAAGAAGG CCGTGAACGACGTGAATGGCCTGAAGCAATGTTTGGCAGAATTCAAGCGGGATCTGGAATGGGTTGAAAGGCTCGATGTGACACTGGGTC CGGTACCGGAGATCGGTGGATCTGAGGCGCCAGCACCTCAGAACAAGGACCAGAAAGCTGTTGATCCAGAAGACGACTTCCAGCGAGAGA TGAGTTTCTATCGCCAAGCCCAGGCCGCAGTGCTTGCAGTCTTACCCCGCCTCCATCAGCTCAAAGTCCCTACGAAGCGACCCACTGATT ATTTTGCGGAAATGGCCAAATCTGATCTGCAGATGCAGAAGATTCGACAGAAGCTGCAGACTAAACAGGCTGCCATGGAGAGGTCTGAAA AAGCTAAGCAACTGCGAGCACTTAGGAAATACGGGAAGAAGGACCATGCAGAGGAGGGCAGGGCTAGCATTTACAAATCAGTCTTTTCCA ACTCTTCCAAAGAGATGATGTGTTTCCCAGACTTCCCATTTCCCGATGACTTCCCCAACTTTATGCACAACAGCAAGATCCAGGAATATA TCATTGCATTTGCCAAAGAAAAGAACCTCCTGAAGTACATACAATTTAAGACATTTGTATCCAGTGTAAATAAACATCCTGATTTTGCAA CTACTGGCCAGTGGGATGTTACCACTGAAAGGGATGGTAAAAAAGAATCGGCTGTCTTTGATGCTGTAATGGTTTGTTCCGGACATCATG TGTATCCCAACCTACCAAAAGAGTCCTTTCCAGGACTAAACCACTTTAAAGGCAAATGCTTCCACAGCAGGGACTATAAAGAACCAGGTG TATTCAATGGAAAGCGTGTCCTGGTGGTTGGCCTGGGGAATTCGGGCTGTGATATTGCCACAGAACTCAGCCGCACAGCAGAACAGGTCA TGATCAGTTCCAGAAGTGGCTCCTGGGTGATGAGCCGGGTCTGGGACAATGGTTATCCTTGGGACATGCTGCTCGTCACTCGATTTGGAA CCTTCCTCAAGAACAATTTACCGACAGCCATCTCTGACTGGTTGTACGTGAAGCAGATGAATGCAAGATTCAAGCATGAAAACTATGGCT TGATGCCTTTAAATGGAGTCCTGAGGAAAGAGCCTGTATTTAACGATGAGCTCCCAGCAAGCATTCTGTGTGGCATTGTGTCCGTAAAGC CTAACGTGAAGGAATTCACAGAGACCTCGGCCATTTTTGAGGATGGGACCATATTTGAGGGCATTGACTGTGTAATCTTTGCAACAGGGT ATAGTTTTGCCTACCCCTTCCTTGATGAGTCTATCATCAAAAGCAGAAACAATGAGATCATTTTATTTAAAGGAGTATTTCCTCCTCTAC TTGAGAAGTCAACCATAGCAGTGATTGGCTTTGTCCAGTCCCTTGGGGCTGCCATTCCCACAGTTGACCTCCAGTCCCGCTGGGCAGCAC AAGTAATAAAGGGAACTTGTACTTTGCCTTCTATGGAAGACATGATGAATGATATTAATGAGAAAATGGAGAAAAAGCGCAAATGGTTTG GCAAAAGCGAGACCATACAGACAGATTACATTGTTTATATGGATGAACTCTCCTCCTTCATTGGGGCAAAGCCCAACATCCCATGGCTGT TTCTCACAGATCCCAAATTGGCCATGGAAGTTTATTTTGGCCCTTGTAGTCCCTACCAGTTTAGGCTGGTGGGCCCAGGGCAGTGGCCAG GAGCCAGAAATGCCATACTGACCCAGTGGGACCGGTCGTTGAAACCCATGCAGACACGAGTGGTCGGGAGACTTCAGAAGCCTTGCTTCT TTTTCCATTGGCTGAAGCTCTTTGCAATTCCTATTCTGTTAATCGCTGTTTTCCTTGTGTTGACCTAATCATCATTTTCTCTAGGATTTC >In-frame_ENST00000431635_ENST00000542847_TCGA-EP-A3RK-01A_EBNA1BP2_chr1_43634610_-_FMO3_chr1_171072926_length(amino acids)=755AA_start in transcript=50_stop in transcript=2317 MPFPLYPHCYQLLLATPRYPLPPFVSLWVSRPRMYPEALPVGILSNPDTFKRRSGSYSNDKPEVWFAAGSGSPNQKLSSSCVGRACGEMD TPPLSDSESESDESLVTDRELQDAFSRGLLKPGLNVVLEGPKKAVNDVNGLKQCLAEFKRDLEWVERLDVTLGPVPEIGGSEAPAPQNKD QKAVDPEDDFQREMSFYRQAQAAVLAVLPRLHQLKVPTKRPTDYFAEMAKSDLQMQKIRQKLQTKQAAMERSEKAKQLRALRKYGKKDHA EEGRASIYKSVFSNSSKEMMCFPDFPFPDDFPNFMHNSKIQEYIIAFAKEKNLLKYIQFKTFVSSVNKHPDFATTGQWDVTTERDGKKES AVFDAVMVCSGHHVYPNLPKESFPGLNHFKGKCFHSRDYKEPGVFNGKRVLVVGLGNSGCDIATELSRTAEQVMISSRSGSWVMSRVWDN GYPWDMLLVTRFGTFLKNNLPTAISDWLYVKQMNARFKHENYGLMPLNGVLRKEPVFNDELPASILCGIVSVKPNVKEFTETSAIFEDGT IFEGIDCVIFATGYSFAYPFLDESIIKSRNNEIILFKGVFPPLLEKSTIAVIGFVQSLGAAIPTVDLQSRWAAQVIKGTCTLPSMEDMMN DINEKMEKKRKWFGKSETIQTDYIVYMDELSSFIGAKPNIPWLFLTDPKLAMEVYFGPCSPYQFRLVGPGQWPGARNAILTQWDRSLKPM -------------------------------------------------------------- >In-frame_ENST00000236051_ENST00000392085_TCGA-EP-A3RK-01A_EBNA1BP2_chr1_43634610_-_FMO3_chr1_171072926_length(transcript)=2519nt_BP=679nt GCGATTCGGTGGCACGTGGAGCCACGGCGTGGGAGTAGGGGGCTGAAGGCAGGCAGCAGCGGCCAGGGCCGCCCTCTGCTAGCCGCTTGG GTCTCGGGATACCCCGTTTCTTCCTGTAGGTGTGGGACGTGCGTGCGGCGAGATGGACACTCCCCCGCTCTCGGATTCGGAGTCGGAATC CGATGAATCCCTTGTCACAGACAGAGAGTTGCAGGATGCGTTTTCCCGAGGGCTTCTGAAGCCAGGCCTCAATGTCGTGCTAGAGGGGCC GAAGAAGGCCGTGAACGACGTGAATGGCCTGAAGCAATGTTTGGCAGAATTCAAGCGGGATCTGGAATGGGTTGAAAGGCTCGATGTGAC ACTGGGTCCGGTACCGGAGATCGGTGGATCTGAGGCGCCAGCACCTCAGAACAAGGACCAGAAAGCTGTTGATCCAGAAGACGACTTCCA GCGAGAGATGAGTTTCTATCGCCAAGCCCAGGCCGCAGTGCTTGCAGTCTTACCCCGCCTCCATCAGCTCAAAGTCCCTACGAAGCGACC CACTGATTATTTTGCGGAAATGGCCAAATCTGATCTGCAGATGCAGAAGATTCGACAGAAGCTGCAGACTAAACAGGCTGCCATGGAGAG GTCTGAAAAAGCTAAGCAACTGCGAGCACTTAGGAAATACGGGAAGAAGGACCATGCAGAGGAGGGCAGGGCTAGCATTTACAAATCAGT CTTTTCCAACTCTTCCAAAGAGATGATGTGTTTCCCAGACTTCCCATTTCCCGATGACTTCCCCAACTTTATGCACAACAGCAAGATCCA GGAATATATCATTGCATTTGCCAAAGAAAAGAACCTCCTGAAGTACATACAATTTAAGACATTTGTATCCAGTGTAAATAAACATCCTGA TTTTGCAACTACTGGCCAGTGGGATGTTACCACTGAAAGGGATGGTAAAAAAGAATCGGCTGTCTTTGATGCTGTAATGGTTTGTTCCGG ACATCATGTGTATCCCAACCTACCAAAAGAGTCCTTTCCAGGACTAAACCACTTTAAAGGCAAATGCTTCCACAGCAGGGACTATAAAGA ACCAGGTGTATTCAATGGAAAGCGTGTCCTGGTGGTTGGCCTGGGGAATTCGGGCTGTGATATTGCCACAGAACTCAGCCGCACAGCAGA ACAGGTCATGATCAGTTCCAGAAGTGGCTCCTGGGTGATGAGCCGGGTCTGGGACAATGGTTATCCTTGGGACATGCTGCTCGTCACTCG ATTTGGAACCTTCCTCAAGAACAATTTACCGACAGCCATCTCTGACTGGTTGTACGTGAAGCAGATGAATGCAAGATTCAAGCATGAAAA CTATGGCTTGATGCCTTTAAATGGAGTCCTGAGGAAAGAGCCTGTATTTAACGATGAGCTCCCAGCAAGCATTCTGTGTGGCATTGTGTC CGTAAAGCCTAACGTGAAGGAATTCACAGAGACCTCGGCCATTTTTGAGGATGGGACCATATTTGAGGGCATTGACTGTGTAATCTTTGC AACAGGGTATAGTTTTGCCTACCCCTTCCTTGATGAGTCTATCATCAAAAGCAGAAACAATGAGATCATTTTATTTAAAGGAGTATTTCC TCCTCTACTTGAGAAGTCAACCATAGCAGTGATTGGCTTTGTCCAGTCCCTTGGGGCTGCCATTCCCACAGTTGACCTCCAGTCCCGCTG GGCAGCACAAGTAATAAAGGGAACTTGTACTTTGCCTTCTATGGAAGACATGATGAATGATATTAATGAGAAAATGGAGAAAAAGCGCAA ATGGTTTGGCAAAAGCGAGACCATACAGACAGATTACATTGTTTATATGGATGAACTCTCCTCCTTCATTGGGGCAAAGCCCAACATCCC ATGGCTGTTTCTCACAGATCCCAAATTGGCCATGGAAGTTTATTTTGGCCCTTGTAGTCCCTACCAGTTTAGGCTGGTGGGCCCAGGGCA GTGGCCAGGAGCCAGAAATGCCATACTGACCCAGTGGGACCGGTCGTTGAAACCCATGCAGACACGAGTGGTCGGGAGACTTCAGAAGCC TTGCTTCTTTTTCCATTGGCTGAAGCTCTTTGCAATTCCTATTCTGTTAATCGCTGTTTTCCTTGTGTTGACCTAATCATCATTTTCTCT AGGATTTCTGAAAGTTACTGACAATACCCAGACAGGGGCTTTGCTATTTAAAAATTAAAATTTTCACACCACCTGCTTTTCTATTCAGCA TCTTTTGCAGTACTCTGTAGACATTAGTCAGTAATACAGTGTTATTTCTAGGCTCTGAAATAGCCACTTTAAGAATCATGTCATGATCTT AAGAGAGCACTAATCATTTCTGTTTGAGTTCCACTAACACTTCAAAATCAGAACTATGTTCTTTATATCTAACTTAAATCATTTCCTGAA >In-frame_ENST00000236051_ENST00000392085_TCGA-EP-A3RK-01A_EBNA1BP2_chr1_43634610_-_FMO3_chr1_171072926_length(amino acids)=667AA_start in transcript=142_stop in transcript=2145 MDTPPLSDSESESDESLVTDRELQDAFSRGLLKPGLNVVLEGPKKAVNDVNGLKQCLAEFKRDLEWVERLDVTLGPVPEIGGSEAPAPQN KDQKAVDPEDDFQREMSFYRQAQAAVLAVLPRLHQLKVPTKRPTDYFAEMAKSDLQMQKIRQKLQTKQAAMERSEKAKQLRALRKYGKKD HAEEGRASIYKSVFSNSSKEMMCFPDFPFPDDFPNFMHNSKIQEYIIAFAKEKNLLKYIQFKTFVSSVNKHPDFATTGQWDVTTERDGKK ESAVFDAVMVCSGHHVYPNLPKESFPGLNHFKGKCFHSRDYKEPGVFNGKRVLVVGLGNSGCDIATELSRTAEQVMISSRSGSWVMSRVW DNGYPWDMLLVTRFGTFLKNNLPTAISDWLYVKQMNARFKHENYGLMPLNGVLRKEPVFNDELPASILCGIVSVKPNVKEFTETSAIFED GTIFEGIDCVIFATGYSFAYPFLDESIIKSRNNEIILFKGVFPPLLEKSTIAVIGFVQSLGAAIPTVDLQSRWAAQVIKGTCTLPSMEDM MNDINEKMEKKRKWFGKSETIQTDYIVYMDELSSFIGAKPNIPWLFLTDPKLAMEVYFGPCSPYQFRLVGPGQWPGARNAILTQWDRSLK -------------------------------------------------------------- >In-frame_ENST00000236051_ENST00000367755_TCGA-EP-A3RK-01A_EBNA1BP2_chr1_43634610_-_FMO3_chr1_171072926_length(transcript)=2523nt_BP=679nt GCGATTCGGTGGCACGTGGAGCCACGGCGTGGGAGTAGGGGGCTGAAGGCAGGCAGCAGCGGCCAGGGCCGCCCTCTGCTAGCCGCTTGG GTCTCGGGATACCCCGTTTCTTCCTGTAGGTGTGGGACGTGCGTGCGGCGAGATGGACACTCCCCCGCTCTCGGATTCGGAGTCGGAATC CGATGAATCCCTTGTCACAGACAGAGAGTTGCAGGATGCGTTTTCCCGAGGGCTTCTGAAGCCAGGCCTCAATGTCGTGCTAGAGGGGCC GAAGAAGGCCGTGAACGACGTGAATGGCCTGAAGCAATGTTTGGCAGAATTCAAGCGGGATCTGGAATGGGTTGAAAGGCTCGATGTGAC ACTGGGTCCGGTACCGGAGATCGGTGGATCTGAGGCGCCAGCACCTCAGAACAAGGACCAGAAAGCTGTTGATCCAGAAGACGACTTCCA GCGAGAGATGAGTTTCTATCGCCAAGCCCAGGCCGCAGTGCTTGCAGTCTTACCCCGCCTCCATCAGCTCAAAGTCCCTACGAAGCGACC CACTGATTATTTTGCGGAAATGGCCAAATCTGATCTGCAGATGCAGAAGATTCGACAGAAGCTGCAGACTAAACAGGCTGCCATGGAGAG GTCTGAAAAAGCTAAGCAACTGCGAGCACTTAGGAAATACGGGAAGAAGGACCATGCAGAGGAGGGCAGGGCTAGCATTTACAAATCAGT CTTTTCCAACTCTTCCAAAGAGATGATGTGTTTCCCAGACTTCCCATTTCCCGATGACTTCCCCAACTTTATGCACAACAGCAAGATCCA GGAATATATCATTGCATTTGCCAAAGAAAAGAACCTCCTGAAGTACATACAATTTAAGACATTTGTATCCAGTGTAAATAAACATCCTGA TTTTGCAACTACTGGCCAGTGGGATGTTACCACTGAAAGGGATGGTAAAAAAGAATCGGCTGTCTTTGATGCTGTAATGGTTTGTTCCGG ACATCATGTGTATCCCAACCTACCAAAAGAGTCCTTTCCAGGACTAAACCACTTTAAAGGCAAATGCTTCCACAGCAGGGACTATAAAGA ACCAGGTGTATTCAATGGAAAGCGTGTCCTGGTGGTTGGCCTGGGGAATTCGGGCTGTGATATTGCCACAGAACTCAGCCGCACAGCAGA ACAGGTCATGATCAGTTCCAGAAGTGGCTCCTGGGTGATGAGCCGGGTCTGGGACAATGGTTATCCTTGGGACATGCTGCTCGTCACTCG ATTTGGAACCTTCCTCAAGAACAATTTACCGACAGCCATCTCTGACTGGTTGTACGTGAAGCAGATGAATGCAAGATTCAAGCATGAAAA CTATGGCTTGATGCCTTTAAATGGAGTCCTGAGGAAAGAGCCTGTATTTAACGATGAGCTCCCAGCAAGCATTCTGTGTGGCATTGTGTC CGTAAAGCCTAACGTGAAGGAATTCACAGAGACCTCGGCCATTTTTGAGGATGGGACCATATTTGAGGGCATTGACTGTGTAATCTTTGC AACAGGGTATAGTTTTGCCTACCCCTTCCTTGATGAGTCTATCATCAAAAGCAGAAACAATGAGATCATTTTATTTAAAGGAGTATTTCC TCCTCTACTTGAGAAGTCAACCATAGCAGTGATTGGCTTTGTCCAGTCCCTTGGGGCTGCCATTCCCACAGTTGACCTCCAGTCCCGCTG GGCAGCACAAGTAATAAAGGGAACTTGTACTTTGCCTTCTATGGAAGACATGATGAATGATATTAATGAGAAAATGGAGAAAAAGCGCAA ATGGTTTGGCAAAAGCGAGACCATACAGACAGATTACATTGTTTATATGGATGAACTCTCCTCCTTCATTGGGGCAAAGCCCAACATCCC ATGGCTGTTTCTCACAGATCCCAAATTGGCCATGGAAGTTTATTTTGGCCCTTGTAGTCCCTACCAGTTTAGGCTGGTGGGCCCAGGGCA GTGGCCAGGAGCCAGAAATGCCATACTGACCCAGTGGGACCGGTCGTTGAAACCCATGCAGACACGAGTGGTCGGGAGACTTCAGAAGCC TTGCTTCTTTTTCCATTGGCTGAAGCTCTTTGCAATTCCTATTCTGTTAATCGCTGTTTTCCTTGTGTTGACCTAATCATCATTTTCTCT AGGATTTCTGAAAGTTACTGACAATACCCAGACAGGGGCTTTGCTATTTAAAAATTAAAATTTTCACACCACCTGCTTTTCTATTCAGCA TCTTTTGCAGTACTCTGTAGACATTAGTCAGTAATACAGTGTTATTTCTAGGCTCTGAAATAGCCACTTTAAGAATCATGTCATGATCTT AAGAGAGCACTAATCATTTCTGTTTGAGTTCCACTAACACTTCAAAATCAGAACTATGTTCTTTATATCTAACTTAAATCATTTCCTGAA ACATTTTGACATGATTCCTTTTTCCTTTTAAACAATGTATGAAAGATGTATTTTAAATCTAAATAAAGAGCAAATTAAGCAGAATAATTA >In-frame_ENST00000236051_ENST00000367755_TCGA-EP-A3RK-01A_EBNA1BP2_chr1_43634610_-_FMO3_chr1_171072926_length(amino acids)=667AA_start in transcript=142_stop in transcript=2145 MDTPPLSDSESESDESLVTDRELQDAFSRGLLKPGLNVVLEGPKKAVNDVNGLKQCLAEFKRDLEWVERLDVTLGPVPEIGGSEAPAPQN KDQKAVDPEDDFQREMSFYRQAQAAVLAVLPRLHQLKVPTKRPTDYFAEMAKSDLQMQKIRQKLQTKQAAMERSEKAKQLRALRKYGKKD HAEEGRASIYKSVFSNSSKEMMCFPDFPFPDDFPNFMHNSKIQEYIIAFAKEKNLLKYIQFKTFVSSVNKHPDFATTGQWDVTTERDGKK ESAVFDAVMVCSGHHVYPNLPKESFPGLNHFKGKCFHSRDYKEPGVFNGKRVLVVGLGNSGCDIATELSRTAEQVMISSRSGSWVMSRVW DNGYPWDMLLVTRFGTFLKNNLPTAISDWLYVKQMNARFKHENYGLMPLNGVLRKEPVFNDELPASILCGIVSVKPNVKEFTETSAIFED GTIFEGIDCVIFATGYSFAYPFLDESIIKSRNNEIILFKGVFPPLLEKSTIAVIGFVQSLGAAIPTVDLQSRWAAQVIKGTCTLPSMEDM MNDINEKMEKKRKWFGKSETIQTDYIVYMDELSSFIGAKPNIPWLFLTDPKLAMEVYFGPCSPYQFRLVGPGQWPGARNAILTQWDRSLK -------------------------------------------------------------- >In-frame_ENST00000236051_ENST00000542847_TCGA-EP-A3RK-01A_EBNA1BP2_chr1_43634610_-_FMO3_chr1_171072926_length(transcript)=2171nt_BP=679nt GCGATTCGGTGGCACGTGGAGCCACGGCGTGGGAGTAGGGGGCTGAAGGCAGGCAGCAGCGGCCAGGGCCGCCCTCTGCTAGCCGCTTGG GTCTCGGGATACCCCGTTTCTTCCTGTAGGTGTGGGACGTGCGTGCGGCGAGATGGACACTCCCCCGCTCTCGGATTCGGAGTCGGAATC CGATGAATCCCTTGTCACAGACAGAGAGTTGCAGGATGCGTTTTCCCGAGGGCTTCTGAAGCCAGGCCTCAATGTCGTGCTAGAGGGGCC GAAGAAGGCCGTGAACGACGTGAATGGCCTGAAGCAATGTTTGGCAGAATTCAAGCGGGATCTGGAATGGGTTGAAAGGCTCGATGTGAC ACTGGGTCCGGTACCGGAGATCGGTGGATCTGAGGCGCCAGCACCTCAGAACAAGGACCAGAAAGCTGTTGATCCAGAAGACGACTTCCA GCGAGAGATGAGTTTCTATCGCCAAGCCCAGGCCGCAGTGCTTGCAGTCTTACCCCGCCTCCATCAGCTCAAAGTCCCTACGAAGCGACC CACTGATTATTTTGCGGAAATGGCCAAATCTGATCTGCAGATGCAGAAGATTCGACAGAAGCTGCAGACTAAACAGGCTGCCATGGAGAG GTCTGAAAAAGCTAAGCAACTGCGAGCACTTAGGAAATACGGGAAGAAGGACCATGCAGAGGAGGGCAGGGCTAGCATTTACAAATCAGT CTTTTCCAACTCTTCCAAAGAGATGATGTGTTTCCCAGACTTCCCATTTCCCGATGACTTCCCCAACTTTATGCACAACAGCAAGATCCA GGAATATATCATTGCATTTGCCAAAGAAAAGAACCTCCTGAAGTACATACAATTTAAGACATTTGTATCCAGTGTAAATAAACATCCTGA TTTTGCAACTACTGGCCAGTGGGATGTTACCACTGAAAGGGATGGTAAAAAAGAATCGGCTGTCTTTGATGCTGTAATGGTTTGTTCCGG ACATCATGTGTATCCCAACCTACCAAAAGAGTCCTTTCCAGGACTAAACCACTTTAAAGGCAAATGCTTCCACAGCAGGGACTATAAAGA ACCAGGTGTATTCAATGGAAAGCGTGTCCTGGTGGTTGGCCTGGGGAATTCGGGCTGTGATATTGCCACAGAACTCAGCCGCACAGCAGA ACAGGTCATGATCAGTTCCAGAAGTGGCTCCTGGGTGATGAGCCGGGTCTGGGACAATGGTTATCCTTGGGACATGCTGCTCGTCACTCG ATTTGGAACCTTCCTCAAGAACAATTTACCGACAGCCATCTCTGACTGGTTGTACGTGAAGCAGATGAATGCAAGATTCAAGCATGAAAA CTATGGCTTGATGCCTTTAAATGGAGTCCTGAGGAAAGAGCCTGTATTTAACGATGAGCTCCCAGCAAGCATTCTGTGTGGCATTGTGTC CGTAAAGCCTAACGTGAAGGAATTCACAGAGACCTCGGCCATTTTTGAGGATGGGACCATATTTGAGGGCATTGACTGTGTAATCTTTGC AACAGGGTATAGTTTTGCCTACCCCTTCCTTGATGAGTCTATCATCAAAAGCAGAAACAATGAGATCATTTTATTTAAAGGAGTATTTCC TCCTCTACTTGAGAAGTCAACCATAGCAGTGATTGGCTTTGTCCAGTCCCTTGGGGCTGCCATTCCCACAGTTGACCTCCAGTCCCGCTG GGCAGCACAAGTAATAAAGGGAACTTGTACTTTGCCTTCTATGGAAGACATGATGAATGATATTAATGAGAAAATGGAGAAAAAGCGCAA ATGGTTTGGCAAAAGCGAGACCATACAGACAGATTACATTGTTTATATGGATGAACTCTCCTCCTTCATTGGGGCAAAGCCCAACATCCC ATGGCTGTTTCTCACAGATCCCAAATTGGCCATGGAAGTTTATTTTGGCCCTTGTAGTCCCTACCAGTTTAGGCTGGTGGGCCCAGGGCA GTGGCCAGGAGCCAGAAATGCCATACTGACCCAGTGGGACCGGTCGTTGAAACCCATGCAGACACGAGTGGTCGGGAGACTTCAGAAGCC TTGCTTCTTTTTCCATTGGCTGAAGCTCTTTGCAATTCCTATTCTGTTAATCGCTGTTTTCCTTGTGTTGACCTAATCATCATTTTCTCT >In-frame_ENST00000236051_ENST00000542847_TCGA-EP-A3RK-01A_EBNA1BP2_chr1_43634610_-_FMO3_chr1_171072926_length(amino acids)=667AA_start in transcript=142_stop in transcript=2145 MDTPPLSDSESESDESLVTDRELQDAFSRGLLKPGLNVVLEGPKKAVNDVNGLKQCLAEFKRDLEWVERLDVTLGPVPEIGGSEAPAPQN KDQKAVDPEDDFQREMSFYRQAQAAVLAVLPRLHQLKVPTKRPTDYFAEMAKSDLQMQKIRQKLQTKQAAMERSEKAKQLRALRKYGKKD HAEEGRASIYKSVFSNSSKEMMCFPDFPFPDDFPNFMHNSKIQEYIIAFAKEKNLLKYIQFKTFVSSVNKHPDFATTGQWDVTTERDGKK ESAVFDAVMVCSGHHVYPNLPKESFPGLNHFKGKCFHSRDYKEPGVFNGKRVLVVGLGNSGCDIATELSRTAEQVMISSRSGSWVMSRVW DNGYPWDMLLVTRFGTFLKNNLPTAISDWLYVKQMNARFKHENYGLMPLNGVLRKEPVFNDELPASILCGIVSVKPNVKEFTETSAIFED GTIFEGIDCVIFATGYSFAYPFLDESIIKSRNNEIILFKGVFPPLLEKSTIAVIGFVQSLGAAIPTVDLQSRWAAQVIKGTCTLPSMEDM MNDINEKMEKKRKWFGKSETIQTDYIVYMDELSSFIGAKPNIPWLFLTDPKLAMEVYFGPCSPYQFRLVGPGQWPGARNAILTQWDRSLK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for EBNA1BP2-FMO3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EBNA1BP2-FMO3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for EBNA1BP2-FMO3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | FMO3 | C0342739 | Trimethylaminuria | 9 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | FMO3 | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Tgene | FMO3 | C0032580 | Adenomatous Polyposis Coli | 1 | CTD_human |
Tgene | FMO3 | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Tgene | FMO3 | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Tgene | FMO3 | C2713442 | Polyposis, Adenomatous Intestinal | 1 | CTD_human |
Tgene | FMO3 | C2713443 | Familial Intestinal Polyposis | 1 | CTD_human |
Tgene | FMO3 | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Tgene | FMO3 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | FMO3 | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |